Bluejay Diagnostics, Inc. (BJDX)
USD 3.54
(8.92%)
USD 3.54
(8.92%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -9.17 Million USD | -5.19% |
| 2022 | -8.99 Million USD | -188.94% |
| 2021 | -3.08 Million USD | -185.33% |
| 2020 | -1.03 Million USD | 26.65% |
| 2019 | -1.48 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -1.84 Million USD | 24.37% |
| 2024 Q1 | -2.37 Million USD | -0.4% |
| 2023 Q2 | -2.61 Million USD | 2.59% |
| 2023 FY | - USD | -5.19% |
| 2023 Q4 | -2.33 Million USD | -12.56% |
| 2023 Q3 | -2.07 Million USD | 20.68% |
| 2023 Q1 | -2.67 Million USD | -14.67% |
| 2022 Q2 | -1.93 Million USD | 3.77% |
| 2022 Q1 | -2.01 Million USD | -54.36% |
| 2022 FY | - USD | -188.94% |
| 2022 Q4 | -2.33 Million USD | 10.13% |
| 2022 Q3 | -2.6 Million USD | -34.2% |
| 2021 Q2 | -567.39 Thousand USD | -178.85% |
| 2021 Q4 | -1.3 Million USD | -36.16% |
| 2021 Q3 | -957.98 Thousand USD | -68.84% |
| 2021 Q1 | -203.47 Thousand USD | 68.24% |
| 2021 FY | - USD | -185.33% |
| 2020 Q1 | -196.7 Thousand USD | 0.0% |
| 2020 Q4 | -640.77 Thousand USD | -460.11% |
| 2020 Q3 | -114.4 Thousand USD | 41.84% |
| 2020 Q2 | -196.7 Thousand USD | 0.0% |
| 2020 FY | - USD | 26.65% |
| 2019 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 81.57% |
| BrainsWay Ltd. | -2.31 Million USD | -296.925% |
| Cerus Corporation | -26.53 Million USD | 65.432% |
| Envoy Medical, Inc. | -18.23 Million USD | 49.704% |
| electroCore, Inc. | -17.76 Million USD | 48.351% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 24.234% |
| IceCure Medical Ltd | -15.25 Million USD | 39.861% |
| Inogen, Inc. | -45.67 Million USD | 79.919% |
| OrthoPediatrics Corp. | -8.38 Million USD | -9.449% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 81.562% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 45.58% |
| MaxCyte, Inc. | -44.12 Million USD | 79.213% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 21.972% |
| Nexalin Technology, Inc. | -5.69 Million USD | -61.154% |
| Orthofix Medical Inc. | -86.98 Million USD | 89.455% |
| PAVmed Inc | -75.74 Million USD | 87.889% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 82.937% |
| RxSight, Inc. | -41.03 Million USD | 77.647% |
| Sight Sciences, Inc. | -49.41 Million USD | 81.437% |
| SI-BONE, Inc. | -34.44 Million USD | 73.37% |
| TELA Bio, Inc. | -40.63 Million USD | 77.425% |
| Treace Medical Concepts, Inc. | -39 Million USD | 76.484% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 44.99% |
| Acutus Medical, Inc. | -13.48 Million USD | 31.987% |
| Talis Biomedical Corporation | -66.04 Million USD | 86.111% |
| Spectral AI, Inc. | -12.26 Million USD | 25.192% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 80.767% |
| CVRx, Inc. | -38.73 Million USD | 76.316% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -160.004% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 12.593% |
| Bioventus Inc. | -23.07 Million USD | 60.239% |
| Venus Concept Inc. | -26.11 Million USD | 64.872% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 84.265% |
| LivaNova PLC | 39.01 Million USD | 123.511% |
| 908 Devices Inc. | -34.02 Million USD | 73.041% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 91.706% |
| Nemaura Medical Inc. | -7.28 Million USD | -25.88% |
| NeuroPace, Inc. | -22.83 Million USD | 59.828% |
| LENSAR, Inc. | -8.71 Million USD | -5.267% |
| Apyx Medical Corporation | -18.11 Million USD | 49.354% |
| Cutera, Inc. | -136.56 Million USD | 93.283% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -171.389% |
| BioSig Technologies, Inc. | -28.15 Million USD | 67.415% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 464.584% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 56.296% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 102.391% |
| Axonics, Inc. | 7.77 Million USD | 217.98% |
| Outset Medical, Inc. | -153.78 Million USD | 94.035% |
| IRIDEX Corporation | -7.44 Million USD | -23.16% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 90.649% |
| IRadimed Corporation | 20.8 Million USD | 144.099% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -13.78% |
| INVO Bioscience, Inc. | -6.88 Million USD | -33.327% |
| Telesis Bio, Inc. | -40.49 Million USD | 77.347% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 125.01% |
| Varex Imaging Corporation | 67.2 Million USD | 113.65% |
| Quipt Home Medical Corp. | 44.07 Million USD | 120.814% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 15.612% |
| Pulmonx Corporation | -55.09 Million USD | 83.35% |
| Dynatronics Corporation | -976 Thousand USD | -839.842% |
| Modular Medical, Inc. | -17.1 Million USD | 46.367% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 36.673% |
| Semler Scientific, Inc. | 23.58 Million USD | 138.886% |
| InMode Ltd. | 196.28 Million USD | 104.673% |
| Bruker Corporation | 599 Million USD | 101.531% |
| Cytosorbents Corporation | -28.81 Million USD | 68.161% |
| DexCom, Inc. | 916.7 Million USD | 101.001% |
| Align Technology, Inc. | 799.03 Million USD | 101.148% |
| Viveve Medical, Inc. | -20.61 Million USD | 55.508% |
| ZimVie Inc. | 91.07 Million USD | 110.072% |
| Movano Inc. | -29.12 Million USD | 68.505% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -108.097% |
| Nexalin Technology, Inc. | -5.69 Million USD | -61.154% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -160.004% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 95.288% |
| Profound Medical Corp. | -27.12 Million USD | 66.181% |
| Insulet Corporation | 323.6 Million USD | 102.835% |
| enVVeno Medical Corporation | -25.01 Million USD | 63.335% |
| Surmodics, Inc. | 1.18 Million USD | 872.132% |
| iCAD, Inc. | -6.56 Million USD | -39.725% |
| Nuwellis, Inc. | -16.35 Million USD | 43.917% |
| Biotricity, Inc. | -8.82 Million USD | -3.904% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 90.53% |
| Aethlon Medical, Inc. | -11.84 Million USD | 22.586% |
| InspireMD, Inc. | -20.91 Million USD | 56.133% |
| PAVmed Inc. | -75.74 Million USD | 87.889% |
| BIOLASE, Inc. | -15.13 Million USD | 39.409% |
| Beyond Air, Inc. | -59.03 Million USD | 84.461% |
| FONAR Corporation | 28.25 Million USD | 132.469% |
| AxoGen, Inc. | -13.32 Million USD | 31.175% |
| Vivani Medical, Inc. | -26.6 Million USD | 65.526% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 137.378% |
| Inari Medical, Inc. | 7.11 Million USD | 228.96% |
| UFP Technologies, Inc. | 72.74 Million USD | 112.61% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -170.925% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -49.008% |
| Tenon Medical, Inc. | -15.52 Million USD | 40.927% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 39.913% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 77.884% |
| AdaptHealth Corp. | -171.09 Million USD | 94.639% |
| Sintx Technologies, Inc. | -6.6 Million USD | -38.984% |
| NanoVibronix, Inc. | -3.43 Million USD | -167.043% |
| Quanterix Corporation | -38.08 Million USD | 75.916% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 15.612% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 30676.44% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 96.692% |
| TransMedics Group, Inc. | -7.6 Million USD | -20.649% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 57.855% |
| NeuroMetrix, Inc. | -7.09 Million USD | -29.273% |
| Hyperfine, Inc. | -47.06 Million USD | 80.508% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 84.268% |
| Biomerica, Inc. | -5.99 Million USD | -53.061% |
| Bone Biologics Corporation | 479.57 Thousand USD | 2012.733% |
| AVITA Medical, Inc. | -39.56 Million USD | 76.817% |
| Silk Road Medical, Inc | -45.08 Million USD | 79.652% |